|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.745 SEK | 0.00% |
|
-8.59% | -32.27% |
| 10/04 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 23/02 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Vaxxa AB reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 20.92 million compared to SEK 6.28 million a year ago. Revenue was SEK 21.12 million compared to SEK 6.42 million a year ago.
Net income was SEK 0.312 million compared to net loss of SEK 2.65 million a year ago. Basic earnings per share from continuing operations was SEK 0.012 compared to basic loss per share from continuing operations of SEK 1 a year ago.
VAXXA AB 